These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34440471)

  • 1. Endogenous Mammalian Cardiotonic Steroids-A New Cardiovascular Risk Factor?-A Mini-Review.
    Słabiak-Błaż N; Piecha G
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension.
    Paczula A; Więcek A; Piecha G
    Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.
    Bagrov AY; Shapiro JI; Fedorova OV
    Pharmacol Rev; 2009 Mar; 61(1):9-38. PubMed ID: 19325075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous cardiotonic steroids and salt-sensitive hypertension.
    Fedorova OV; Shapiro JI; Bagrov AY
    Biochim Biophys Acta; 2010 Dec; 1802(12):1230-6. PubMed ID: 20347967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whither digitalis? What we can still learn from cardiotonic steroids about heart failure and hypertension.
    Blaustein MP; Gottlieb SS; Hamlyn JM; Leenen FHH
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1281-H1295. PubMed ID: 36367691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous digitalis: pathophysiologic roles and therapeutic applications.
    Bagrov AY; Shapiro JI
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):378-92. PubMed ID: 18542120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous cardiotonic steroids and cardiovascular disease, where to next?
    Pavlovic D
    Cell Calcium; 2020 Mar; 86():102156. PubMed ID: 31896530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotonic steroids as potential Na
    Patel CN; Kumar SP; Modi KM; Soni MN; Modi NR; Pandya HA
    J Recept Signal Transduct Res; 2019 Jun; 39(3):226-234. PubMed ID: 31509043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
    Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
    FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
    Oselkin M; Tian D; Bergold PJ
    Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na,K-ATPase as a target for endogenous cardiotonic steroids: What's the evidence?
    Orlov SN; Tverskoi AM; Sidorenko SV; Smolyaninova LV; Lopina OD; Dulin NO; Klimanova EA
    Genes Dis; 2021 May; 8(3):259-271. PubMed ID: 33997173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease.
    Pavlovic D
    Nephron Clin Pract; 2014; 128(1-2):11-21. PubMed ID: 25341357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Trade-Off between Dietary Salt and Cardiovascular Disease; A Role for Na/K-ATPase Signaling?
    Xie JX; Shapiro AP; Shapiro JI
    Front Endocrinol (Lausanne); 2014; 5():97. PubMed ID: 25101054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Na+,K+-ATPase as a Target for Treatment of Tissue Fibrosis.
    Orlov SN; La J; Smolyaninova LV; Dulin NO
    Curr Med Chem; 2019; 26(3):564-575. PubMed ID: 28625151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotonic Steroids Stimulate Macrophage Inflammatory Responses Through a Pathway Involving CD36, TLR4, and Na/K-ATPase.
    Chen Y; Huang W; Yang M; Xin G; Cui W; Xie Z; Silverstein RL
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1462-1469. PubMed ID: 28619997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1
    Marck PV; Pessoa MT; Xu Y; Kutz LC; Collins DM; Yan Y; King C; Wang X; Duan Q; Cai L; Xie JX; Lingrel JB; Xie Z; Tian J; Pierre SV
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Na(+)/K(+)-ATPase as [K(+)](o) sensor: Role in cardiovascular disease pathogenesis and augmented production of endogenous cardiotonic steroids.
    Akimova O; Tremblay J; Hamet P; Orlov SN
    Pathophysiology; 2006 Dec; 13(4):209-16. PubMed ID: 16857351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
    Schoner W; Scheiner-Bobis G
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snakes exhibit tissue-specific variation in cardiotonic steroid sensitivity of Na
    Mohammadi S; Petschenka G; French SS; Mori A; Savitzky AH
    Comp Biochem Physiol B Biochem Mol Biol; 2018 Mar; 217():21-26. PubMed ID: 29223875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.